Indegene Wins 2025 BIG Innovation Award for Hyper-Automated AI Solution

Indegene, a digital-first life sciences commercialization company, announced that it is a winner at the 2025 BIG Innovation Awards. The company's ground-breaking solution, Hyper-automated AI Ecosystem for Accelerated Insights Generation, was recognized as the winner in the 'Product - Business Services' category.

Hyper-automated AI is a unified framework combining AI, ML, RPA, and NLQ to streamline data extraction, quality management, transformation, and actionable insights - all on a single platform.

An initiative by the Business Intelligence Group, the BIG Innovation Awards identify and recognize organizations devoted to bringing new ideas to life - honouring those dedicated to paving a new way for products, services, experiences, and community service. This recognition underscores Indegene's commitment to pushing boundaries, solving real-world challenges, and delivering impactful solutions to customers and communities. The win is also a testimonial of Indegene's continued efforts to help healthcare organizations be future-ready.

Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products. It is one of the very few companies globally where a medical doctor and a data scientist work next to each other to solve big, impactful problems in life sciences. And this is by design. More than 20% of Indegene's employees come from a medical education background and they work very closely with about 600 technologists who work on advanced artificial intelligence (AI), machine learning (ML) and other technologies.

With 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene's client base includes the world's top 20 biopharma companies, many emerging biotech firms, and medical device companies. With over 5,000 employees worldwide, Indegene's vast global footprint underscores its ability to scale and meet the evolving needs of the world's leading pharma organizations across markets.

Shares of Indegene Limited was last trading in BSE at Rs. 652.40 as compared to the previous close of Rs. 638.80. The total number of shares traded during the day was 17035 in over 946 trades.

The stock hit an intraday high of Rs. 657.15 and intraday low of 626.50. The net turnover during the day was Rs. 10984119.00.

Source : Equity Bulls

Keywords

Indegene HealthcareResearch Analytics Technology INE065X01017 2025BIGInnovationAward